NCT06017518 An Observational Study of Local Relapse After High Grade Osteosarcoma
| NCT ID | NCT06017518 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Ortopedico Rizzoli |
| Condition | Osteosarcoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2022-06-13 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2022-06-13 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
multicenter retrospective and prospective study in patients with high-grade osteosarcoma
Eligibility Criteria
Inclusion Criteria: * Patients who experienced LR as first event of recurrence after treatment for localized high-grade osteosarcoma of bone, including cases with synchronous lung metastases * Adequate patient compliance to follow-up visits * Written informed consent prior to any study-specific analysis and/or data collection * No age limits Exclusion Criteria: * Cases of LR demonstrated after \> 3 months after metastatic disease * Impossibility to ensure adequate compliance
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06017518 clinical trial?
This trial is open to participants of all sexes, studying Osteosarcoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06017518 currently recruiting?
Yes, NCT06017518 is actively recruiting participants. Contact the research team at emanuela.palmerini@ior.it for enrollment information.
Where is the NCT06017518 trial being conducted?
This trial is being conducted at Bologna, Italy, Pisa, Italy.
Who is sponsoring the NCT06017518 clinical trial?
NCT06017518 is sponsored by Istituto Ortopedico Rizzoli. The trial plans to enroll 150 participants.